Merck | iPharmaCenter

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter

ipharmaservices

Aug 4, 2022

Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter

0

Breast Cancer News | Blogs | Keytruda, Trodelvy was approved for TNBC | iPhamaCenter

ipharmaservices

Jan 17, 2022

Breast Cancer News | Blogs | Keytruda, Trodelvy was approved for TNBC | iPhamaCenter

0

ESMO 2020

ipharmaservices

Sep 19, 2020

ESMO 2020

0

To strengthen the oncology portfolio, Merck collaborated with Seattle Genetics, and Gilead acquired

ipharmaservices

Sep 18, 2020

To strengthen the oncology portfolio, Merck collaborated with Seattle Genetics, and Gilead acquired

0

Bayer submitted vericiguat for market authorization in China

ipharmaservices

Aug 28, 2020

Bayer submitted vericiguat for market authorization in China

0

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page